Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|January 23, 2023
A novel mRNA vaccine, SYS6006, against SARS-CoV-2Ke Xu, Wenwen Lei, Bin Kang, et al.
Food & Nutrition Research|August 11, 2022
Gardenia jasminoides J. Ellis extract GJ-4 attenuates hyperlipidemic vascular dementia in rats via regulating PPAR-γ-mediated microglial polarizationHui Liu, Caixia Zang, Junmei Shang, et al.
Acta Pharmaceutica Sinica. B|June 1, 2022
PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4α-GLUT2 pathwayPeihua Liu, Ling Jiang, Weimin Kong, et al.
Translational Lung Cancer Research|June 13, 2022
The strategy of non-intubated spontaneous ventilation anesthesia for upper tracheal surgery: a retrospective case series studyYanran Zhou, Hengrui Liang, Ke Xu, et al.
Cell Death Discovery|July 26, 2019
Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1αYongxin Qiu, Wenqi Shan, Ye Yang, et al.
Emerging Microbes & Infections|June 11, 2024
The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trialChunhua Zhou, Yuanzheng Qiu, Jianxin Wang, et al.
Translational Cancer Research|February 4, 2022
Anticancer effect of the traditional Chinese medicine herb Maytenus compound via the EGFR/PI3K/AKT/GSK3β pathwayBaozhen Zeng, Chunlei Ge, Wentao Zhao, et al.
Journal of Thoracic Disease|July 21, 2025
HEs Consciousness Scale: a rapid and promising classification for early assessment of post-anesthesia consciousness recoveryJiawei Chen, Wei Shen, Yanran Zhou, et al.
Vaccine|February 16, 2024
Immunogenicity and safety of a SARS-CoV-2 mRNA vaccine (SYS6006) in healthy Chinese participants: A randomized, observer-blinded, placebo-controlled phase 2 clinical trialFei Jin, Yuanzheng Qiu, Zhiwei Wu, et al.
Acta Pharmaceutica Sinica. B|December 4, 2023
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastomaYingqiang Liu, Zhengsheng Zhan, Zhuang Kang, et al.
Pageof 10